
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-infl... Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.2479 | 0.2479 | 0.2479 | 0 | 0 | CS |
4 | 0 | 0 | 0.2479 | 0.2479 | 0.2479 | 0 | 0 | CS |
12 | 0 | 0 | 0.2479 | 0.2479 | 0.2479 | 0 | 0 | CS |
26 | -0.2975 | -54.5471213788 | 0.5454 | 0.6658 | 0.22 | 1331414 | 0.37014529 | CS |
52 | -1.1121 | -81.7720588235 | 1.36 | 1.94 | 0.22 | 782724 | 0.51251422 | CS |
156 | -4.2521 | -94.4911111111 | 4.5 | 5.27 | 0.22 | 605454 | 0.58593052 | CS |
260 | -4.2521 | -94.4911111111 | 4.5 | 5.27 | 0.22 | 605454 | 0.58593052 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions